Sun Pharma to launch new oral lipid lowering drug under Brillo brand

Claims drug has a new mechanism of action compared to currently available lipid lowering agents, is indicated for people with inherited genetic disorder

Sun Pharmaceutical Industries plans to launch a first in class lipid lowering oral drug - Bempedoic Acid - in India that helps to reduce low-density lipo-protein (LDL) cholesterol. The company will launch the drug under the brand name Brillo, it said.

Sun Pharma claimed that this drug has a new mechanism of action compared to the currently available lipid lowering agents. "It is indicated for people who have an inherited genetic disorder that causes high cholesterol levels or established heart disease where cholesterol levels remain high, despite lifestyle changes and the use of maximum tolerated dose of statins," it said.

Kirti Ganorkar,